WYNN
15
-11
XYL
35
4
TGNA
37
-3
EXPE
77
5
F
42
2
RSG
62
2
BK
69
4
STZ
47
-3
NWSA
78
5
MCO
67
3
MDT
59
2
RIG
58
3
GS
63
11
YUM
43
5
CMA
53
3
APH
65
4
PSA
56
5
HCA
53
3
UNH
55
5
STI
28
9
WYNN
15
-11
XYL
35
4
TGNA
37
-3
EXPE
77
5
F
42
2
RSG
62
2
BK
69
4
STZ
47
-3
NWSA
78
5
MCO
67
3
MDT
59
2
RIG
58
3
GS
63
11
YUM
43
5
CMA
53
3
APH
65
4
PSA
56
5
HCA
53
3
UNH
55
5
STI
28
9
Financhill
Back

AquaBounty Technologies 10K Form

Sell
44

AQB
AquaBounty Technologies

Last Price:
1.10
Seasonality Move:
12.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AQB News And Ratings

See the #1 stock for the next 7 days that we like better than AQB

AQB Financial Statistics

Sales & Book Value

Annual Sales: $2.47M
Cash Flow: $-5.2M
Price / Cash Flow: 0
Annual Sales: $26.73
Price / Book: 0.04

Profitability

EPS (TTM): -19.77000
Net Income (TTM): $-76.24M
Gross Margin: $-12.81M
Return on Equity: -49.2%
Return on Assets: -42.64%

AquaBounty Technologies Earnings Forecast

Key AquaBounty Technologies Financial Ratios

  • The Gross Profit Margin over the past 19 years for AQB is -518.02%.
  • The Selling, General & Administrative Expenses for AQB have been equal to 558.26% of Gross Profit Margin.
  • The Research & Development expenses have been 28.46% of Revenue.
  • The Interest Expense is -1.10% of Operating Income.
  • The Net Earning history of AQB is -1,114.50% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 13 years.

AquaBounty Technologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AQB
CUSIP: 03842K
Website: aquabounty.com

Debt

Debt-to-Equity Ratio: 0.1
Current Ratio: 1.96
Quick Ratio: 0.04

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AQB Technical Analysis vs Fundamental Analysis

Sell
44
AquaBounty Technologies (AQB) is a Sell

Is AquaBounty Technologies a Buy or a Sell?